Vivos Therapeutics (VVOS) Current Taxes (2023 - 2026)

Vivos Therapeutics (VVOS) has reported Current Taxes for 4 consecutive years, with $954000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Taxes rose 51.19% year-over-year to $954000.0 in Q2 2026; TTM through Jun 2026 was $954000.0, a 51.19% increase from a year earlier, with the FY2025 full-year figure at $799000.0, up 66.11% from the prior year.
• Current Taxes was $954000.0 for Q2 2026 at Vivos Therapeutics, up from $877000.0 in the prior quarter.
• Over five years, Current Taxes peaked at $954000.0 in Q2 2026 and troughed at $327000.0 in Q4 2023.
• A 4-year average of $666125.0 and a median of $679000.0 in 2025 frame the typical range for Current Taxes.
• Across the five-year window, Current Taxes jumped 47.09% in 2024 and jumped 66.11% in 2025, its largest moves.
• Over 4 years, Current Taxes stood at $327000.0 in 2023, then jumped by 47.09% to $481000.0 in 2024, then jumped by 66.11% to $799000.0 in 2025, then increased by 19.4% to $954000.0 in 2026.
• The last three Current Taxes figures came in at $954000.0 (Q2 2026), $877000.0 (Q1 2026), and $799000.0 (Q4 2025), per Business Quant data.